These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34592353)

  • 1. Panobinostat reverses HepaCAM gene expression and suppresses proliferation by increasing histone acetylation in prostate cancer.
    Chen E; Liu N; Zhao Y; Tang M; Ou L; Wu X; Luo C
    Gene; 2022 Jan; 808():145977. PubMed ID: 34592353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.
    Vallo S; Mani J; Stastny M; Makarević J; Juengel E; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
    Invest New Drugs; 2013 Apr; 31(2):265-72. PubMed ID: 22801803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer.
    Shankar E; Pandey M; Verma S; Abbas A; Candamo M; Kanwal R; Shukla S; MacLennan GT; Gupta S
    Mol Carcinog; 2020 Aug; 59(8):955-966. PubMed ID: 32391971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells.
    Pettazzoni P; Pizzimenti S; Toaldo C; Sotomayor P; Tagliavacca L; Liu S; Wang D; Minelli R; Ellis L; Atadja P; Ciamporcero E; Dianzani MU; Barrera G; Pili R
    Free Radic Biol Med; 2011 Jan; 50(2):313-22. PubMed ID: 21078383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seleno-aspirin compound AS-10 promotes histone acetylation ahead of suppressing androgen receptor transcription, G1 arrest, and apoptosis of prostate cancer cells.
    Karelia DN; Kim S; Plano D; Sharma AK; Jiang C; Lu J
    Prostate; 2023 Jan; 83(1):16-29. PubMed ID: 35996318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
    Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
    Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent HDAC and mTORC1 inhibition attenuate androgen receptor and hypoxia signaling associated with alterations in microRNA expression.
    Ellis L; Lehet K; Ramakrishnan S; Adelaiye R; Miles KM; Wang D; Liu S; Atadja P; Carducci MA; Pili R
    PLoS One; 2011; 6(11):e27178. PubMed ID: 22087262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
    Fischer C; Leithner K; Wohlkoenig C; Quehenberger F; Bertsch A; Olschewski A; Olschewski H; Hrzenjak A
    Mol Cancer; 2015 Jan; 14():4. PubMed ID: 25608569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation.
    Chuang MJ; Wu ST; Tang SH; Lai XM; Lai HC; Hsu KH; Sun KH; Sun GH; Chang SY; Yu DS; Hsiao PW; Huang SM; Cha TL
    PLoS One; 2013; 8(9):e73401. PubMed ID: 24023871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
    Kling MJ; Kesherwani V; Mishra NK; Alexander G; McIntyre EM; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
    J Exp Clin Cancer Res; 2022 Nov; 41(1):321. PubMed ID: 36357906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines.
    Lopes N; Salta S; Flores BT; Miranda-Gonçalves V; Correia MP; Gigliano D; Guimarães R; Henrique R; Jerónimo C
    Clin Epigenetics; 2024 Aug; 16(1):102. PubMed ID: 39097736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines.
    Fialova B; Smesny Trtkova K; Paskova L; Langova K; Kolar Z
    Oncol Rep; 2013 May; 29(5):2039-45. PubMed ID: 23503510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.
    Chen CH; Huang PH; Chu PC; Chen MC; Chou CC; Wang D; Kulp SK; Teng CM; Wang Q; Chen CS
    J Biol Chem; 2011 Mar; 286(12):9968-76. PubMed ID: 21282102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.
    Thakur VS; Gupta K; Gupta S
    Carcinogenesis; 2012 Feb; 33(2):377-84. PubMed ID: 22114073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity.
    Mehrpouri M; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Momeny M; Bashash D
    Eur J Pharmacol; 2020 May; 875():173050. PubMed ID: 32142770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain.
    Deng Q; Luo L; Quan Z; Liu N; Du Z; Sun W; Luo C; Wu X
    Mol Med Rep; 2019 Mar; 19(3):2115-2124. PubMed ID: 30664187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation.
    He Z; Gao Y; Li T; Yu C; Ou L; Luo C
    Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35191516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
    Chen CQ; Chen CS; Chen JJ; Zhou LP; Xu HL; Jin WW; Wu JB; Gao SM
    Mol Cell Biochem; 2013 Nov; 383(1-2):137-48. PubMed ID: 23867991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.
    Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J
    Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.